Journal of Neuroimmunology
Volume 217, Issue 1 , Pages 38-45 , 10 December 2009

Immune response in lung cancer mouse model mimics human anti-Hu reactivity

  • Meleeneh Kazarian

      Affiliations

    • Departments of Surgery and of Biochemistry and Molecular Biology, Keck School of Medicine, University of Southern California/Norris Cancer Center, 1441 Eastlake Ave. NOR 6420, Norris Cancer Center, Los Angeles, CA 90089, United States
    • Both authors contributed equally to this work.
    • ,
  • Joaquim Calbo

      Affiliations

    • Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 1211066 CX Amsterdam, The Netherlands
    • Both authors contributed equally to this work.
    • ,
  • Natalie Proost

      Affiliations

    • Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 1211066 CX Amsterdam, The Netherlands
    • ,
  • Catherine L. Carpenter

      Affiliations

    • Center for Human Nutrition, David Geffen School of Medicine, University of California Los Angeles, 900 Veteran Ave. Box 951742 Los Angeles, CA 90095, United States
    • ,
  • Anton Berns

      Affiliations

    • Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 1211066 CX Amsterdam, The Netherlands
    • ,
  • Ite A. Laird-Offringa

      Affiliations

    • Departments of Surgery and of Biochemistry and Molecular Biology, Keck School of Medicine, University of Southern California/Norris Cancer Center, 1441 Eastlake Ave. NOR 6420, Norris Cancer Center, Los Angeles, CA 90089, United States
    • Corresponding Author InformationCorresponding author. University of Southern California, 1441 Eastlake Ave. NOR 6420, Norris Cancer Center, Los Angeles, CA 90089, United States. Tel.: +1 323 865 0655; fax: +1 323 865 0158.

Received 24 June 2009 ,Revised 28 August 2009 ,Accepted 28 August 2009.

References 

  1. Abe R, Uyeno Y, Yamamoto K, Sakamoto H. Tissue-specific expression of the gene encoding a mouse RNA binding protein homologous to human HuD antigen. DNA Res. 1994;1:175–180
  2. Aguirre-Cruz L, Charuel JL, Carpentier AF, Benyahia B, Delattre JY, Musset L. Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases. J. Neurooncol. 2005;71:39–41
  3. Anderson NE, Cunningham JM, Posner JB. Autoimmune pathogenesis of paraneoplastic neurological syndromes. Crit. Rev. Neurobiol. 1987;3:245–299
  4. Dalmau J, Posner JB. Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology. 1994;44:2241–2246
  5. Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer—a quantitative western blot analysis. Ann. Neurol. 1990;27:544–552
  6. Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology. 1991;41:1757–1764
  7. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore). 1992;71:59–72
  8. Dalmau J, Graus F, Cheung NK, Rosenblum MK, Ho A, Canete A, et al. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer. 1995;75:99–109
  9. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N. Engl. J. Med. 2003;349:1543–1554
  10. Good PJ. A conserved family of elav-like genes in vertebrates. Proc. Natl. Acad. Sci. U. S. A. 1995;92:4557–4561
  11. Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology. 1985;35:538–543
  12. Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am. J. Med. 1986;80:45–52
  13. Graus F, Dalmou J, Rene R, Tora M, Malats N, Verschuuren JJ, et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J. Clin. Oncol. 1997;15:2866–2872
  14. Graus F, Keime-Guibert F, Rene R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138–1148
  15. Henson RA, Urich H. Cancer in the nervous system. Oxford, England: Blackwell Scientific; 1982;
  16. Horwich MS, Cho L, Porro RS, Posner JB. Subacute sensory neuropathy: a remote effect of carcinoma. Ann. Neurol. 1977;2:7–19
  17. King PH. Differential expression of the neuroendocrine genes Hel-N1 and HuD in small-cell lung carcinoma: evidence for down-regulation of HuD in the variant phenotype. Int. J. Cancer. 1997;74:378–382
  18. Lyons SK, Meuwissen R, Krimpenfort P, Berns A. The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice. Cancer Res. 2003;63:7042–7046
  19. Maddison P, Lang B. Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer. J. Neuroimmunol. 2008;201–202:159–162
  20. Manley GT, Smitt PS, Dalmau J, Posner JB. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann. Neurol. 1995;38:102–110
  21. Meuwissen R, Linn SC, Van Der Valk M, Mooi WJ, Berns A. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene. 2001;20:6551–6558
  22. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell. 2003;4:181–189
  23. Moll JW, Antoine JC, Brashear HR, Delattre J, Drlicek M, Dropcho EJ, et al Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: report from the Workshop to the Fourth Meeting of the International Society of Neuro-Immunology on paraneoplastic neurological disease, held October 22–23, 1994, in Rotterdam, The Netherlands. Neurology. 1995;45:1937–1941
  24. Monstad SE, Drivsholm L, Storstein A, Aarseth JH, Haugen M, Lang B, et al. Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. J. Clin. Oncol. 2004;22:795–800
  25. Park S, Myszka DG, Yu M, Littler SJ, Laird-Offringa IA. HuD RNA recognition motifs play distinct roles in the formation of a stable complex with AU-rich RNA. Mol. Cell. Biol. 2000;20:4765–4772
  26. Park-Lee S, Kim S, Laird-Offringa IA. Characterization of the interaction between neuronal RNA-binding protein HuD and AU-rich RNA. J. Biol. Chem. 2003;278:39801–39808
  27. Posner JB, Dalmau J. Paraneoplastic syndromes. Curr. Opin. Immunol. 1997;9:723–729
  28. Ries LAG, Melbert D, Krapcho M. SEER Cancer Statistics Review, 1975–2004. National Cancer Institute; 2007;
  29. Sandler AB. Chemotherapy for small cell lung cancer. Semin. Oncol. 2003;30:9–25
  30. Sillevis Smitt P, Manley G, Dalmau J, Posner J. The HuD paraneoplastic protein shares immunogenic regions between PEM/PSN patients and several strains and species of experimental animals. J. Neuroimmunol. 1996;71:199–206
  31. Sillevis Smitt P, Grefkens J, De Leeuw B, Van den Bent M, Van Putten W, Hooijkaas H, et al. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J. Neurol. 2002;249:745–753
  32. Sodeyama N, Ishida K, Jaeckle KA, Zhang L, Azuma A, Yamada M, et al. Pattern of epitopic reactivity of the anti-Hu antibody on HuD with and without paraneoplastic syndrome. J. Neurol. Neurosurg. Psychiatry. 1999;66:97–99
  33. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 1979;76:4350–4354
  34. Tsou JA, Kazarian M, Patel A, Galler JS, Laird-Offringa IA, Carpenter CL, et al. Low level anti-Hu reactivity: a risk marker for small cell lung cancer?. Cancer Detect. Prev. 2009;32:292–299
  35. Verschuuren JJ, Perquin M, Ten Velde G, De Baets M, Vriesman PB, Twijnstra A. Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer. J. Neurol. Neurosurg. Psychiatry. 1999;67:353–357
  36. Voltz R, Dalmau J, Posner JB, Rosenfeld MR. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology. 1998;51:1146–1150
  37. Worden FP, Kalemkerian GP. Therapeutic advances in small cell lung cancer. Expert Opin. Investig. Drugs. 2000;9:565–579

PII: S0165-5728(09)00337-3

doi: 10.1016/j.jneuroim.2009.08.014

Journal of Neuroimmunology
Volume 217, Issue 1 , Pages 38-45 , 10 December 2009

Article Tools

* Image Usage & Resolution